Scarica l'app Stockscreener
1.41
3.42%
-0.05
Dopo l'orario di chiusura:
1.49
0.08
+5.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.46
Aprire:
$1.47
Volume 24 ore:
85,524
Relative Volume:
1.03
Capitalizzazione di mercato:
$10.63M
Reddito:
-
Utile/perdita netta:
$-17.43M
Rapporto P/E:
-0.3787
EPS:
-3.7237
Flusso di cassa netto:
$-14.32M
1 W Prestazione:
-5.37%
1M Prestazione:
+0.00%
6M Prestazione:
-28.06%
1 anno Prestazione:
+71.72%
Intervallo 1D:
$1.35
$1.48
Intervallo di 1 settimana:
$1.35
$1.50
Portata 52W:
$0.75
$9.56
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.41 | 11.01M | 0 | -17.43M | -14.32M | -3.7237 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
Small cap wrap: 374Water, Replenish Nutrients, Purepoint Uranium, BioVie… - Proactive financial news
Early Parkinson's trial data from BioVie heads to Chicago meeting - Stock Titan
BioVie abstract on Parkinson’s drug accepted for neurology conference - Proactive financial news
BioVie CEO explains Bezisterim Parkinson’s trial resultsICYMI - Proactive Investors
Fundamentals Check: Will BioVie Inc outperform the market in YEAR2026 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
BioVie targets neuroinflammation and insulin resistance in Parkinson’s treatment approach - Proactive financial news
BIVI Technical Analysis & Stock Price Forecast - Intellectia AI
Rally Mode: What drives BioVie Incs stock priceTrade Ideas & Weekly Top Gainers Alerts - baoquankhu1.vn
If You Invested $1,000 in Biovie Inc (BIVI) - Stock Titan
Trend Report: Will BioVie Inc stock go up in YEAR2026 Movers & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
BIVI Should I Buy - Intellectia AI
Aug Gainers: Is BioVie Inc a turnaround story2026 Major Catalysts & Reliable Price Breakout Alerts - baoquankhu1.vn
BioVie targets Parkinson’s at its source with lead drug bezisterim - Proactive financial news
Analyst Downgrade: Will BioVie Inc outperform the market in YEARQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - The Ames Tribune
Cuong Do Discloses Investment at BioVie Inc. with 5.03% Stake - TradingView
BioVie (NASDAQ: BIVI) CEO Cuong Do discloses 5.03% share stake - Stock Titan
BIVI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
US Market Wrap: Will BioVie Inc stock go up in YEAREarnings Recap Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026 - Bitget
BioVie to present Parkinson’s study data at AD/PD 2026 conference - Proactive financial news
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Green Bay Press-Gazette
BioVie Inc. (BIVI) Discusses Clinical Progress of - One News Page
BioVie Inc. (BIVI) Competitors - Meyka
BIVI,CYRX Dividends - Finviz
BioVie (BIVIW) 10K Form and SEC Filings 2026 - MarketBeat
BioVie (BIVIW) Stock Price, News & Analysis - MarketBeat
BioVie (BIVIW) Stock Chart and Price History 2026 - MarketBeat
BioVie (BIVIW) Stock Trends and Sentiment 2026 - MarketBeat
Top BioVie (BIVIW) Competitors 2026 - MarketBeat
Interview with the President and CEO: BioVie Inc. (NASDAQ:BIVI) - The Wall Street Transcript
BIVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Destin Log
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
BIVIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioVie to host investor webinar on March 4 - Proactive Investors
Join Biovie's Exclusive Live Investor Webinar and Q&A Session on March 4 - Bitget
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4 - The Manila Times
Aug Shorts: Will BioVie Inc stock go up in YEARMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn
BioVie stock dips on pricing $12M securities offering - MSN
BioVie Inc. (NASDAQ:BIVI) Sees Significant Increase in Short Interest - Defense World
Why BioVie Inc. stock is recommended by analystsPortfolio Gains Report & Weekly High Return Stock Opportunities - mfd.ru
Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... - Proactive Investors
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):